018260:KRXSAMSUNG SDS CO., LTD. Analysis
Data as of 2026-06-12 - not real-time
₩237,000.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Samsung SDS is trading well above its 20‑day and 50‑day SMAs (232,090 KRW and 192,918 KRW) and the long‑term 200‑day SMA (173,892 KRW), indicating a bullish price bias, yet the MACD histogram is negative and the MACD signal is bearish, suggesting short‑term momentum weakness. Volume is increasing and the 30‑day volatility is extremely high at 145 %, while beta around 1.4 points to heightened sensitivity to market swings. The current market price of 237,000 KRW sits roughly 34 % above the DCF‑derived fair value of 177,105 KRW, giving a modest overvaluation signal (‑3.45 % upside/downside). Fundamentally, the forward P/E of 20.9 is well below the industry average of 36.5, the dividend yield of 1.39 % is supported by a 38 % payout ratio and strong free cash flow, and the balance sheet shows abundant cash (6.6 T KRW) versus debt (0.84 T KRW) despite a high debt‑to‑equity ratio of 8.2. The company’s growth prospects in AI‑driven logistics and digital transformation offset the valuation premium, but the combination of high volatility, bearish short‑term technicals, and limited upside suggests caution in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating weakening momentum
- Current price exceeds DCF fair value, limiting upside
- High 30‑day volatility and beta increasing downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Forward P/E well below industry average suggests value potential
- Strong cash generation and sustainable dividend support earnings
- Growth opportunities in AI and digital logistics offset valuation premium
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic positioning in high‑growth AI and logistics markets
- Robust balance sheet with net cash position and manageable debt
- Reasonable dividend yield and payout ratio enhancing total return
Key Metrics & Analysis
Financial Health
Revenue Growth-3.90%
Profit Margin4.64%
P/E Ratio20.9
ROE6.58%
ROA3.54%
Debt/Equity8.23
Op. Cash Flow₩1246.2B
Free Cash Flow₩608.2B
Industry P/E36.5
Technical Analysis
TrendBullish
RSI52.5
Support₩161,600.00
Resistance₩388,500.00
MA 20₩232,090.00
MA 50₩192,918.00
MA 200₩173,891.50
MACDBearish
VolumeIncreasing
Fear & Greed Index87.91
Valuation
Fair Value₩177,104.68
Target Price₩228,823.53
Upside/Downside-3.45%
GradeOvervalued
TypeBlend
Dividend Yield1.39%
Risk Assessment
Beta1.42
Volatility145.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.